Abstract:The development of CRISPR-based gene-editing technologies has brought an unprecedented revolution in the field of genome engineering. Cas12a, a member of the Class 2 Type V CRISPR-associated endonuclease family distinct from Cas9, has been repurposed and developed into versatile gene-editing tools with distinct PAM recognition sites and multiplexed gene targeting capability. However, with current CRISPR/Cas12a technologies, it remains a challenge to perform efficient and precise genome editing of long sequences in mammalian cells. To address this limitation, we utilized phage recombination enzymes and developed an efficient CRISPR/Cas12a tool for multiplexed precision editing in mammalian cells. Through protein engineering, we were able to recruit phage recombination proteins to Cas12a to enhance its homology-directed repair efficiencies. Our phage-recombination-assisted Cas12a system achieved up to 3-fold improvements for kilobase-scale knock-ins in human cells without compromising the specificity of the enzyme. The performance of this system compares favorably against Cas9 references, the commonly used enzyme for gene-editing tasks, with improved specificity. Additionally, we demonstrated multi-target editing with similar improved activities thanks to the RNA-processing activity of the Cas12a system. This compact, multi-target editing tool has the potential to assist in understanding multi-gene interactions. In particular, it paves the way for a gene therapy method for human diseases that complements existing tools and is suitable for polygenic disorders and diseases requiring long-sequence corrections.

Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos

Development of miniature base editors using engineered IscB nickase

Engineered IscB-ωRNA system with expanded target range for base editing

Engineering miniature IscB nickase for robust base editing with broad targeting range

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

An engineered Cas12i nuclease that is an efficient genome editing tool in animals and plants

Versatile and Efficient Genome Editing with Neisseria Cinerea Cas9

Genome editing with natural and engineered CjCas9 orthologs

dCas9-based gene editing for cleavage-free genomic knock-in of long sequences

Rationally designed Campylobacter jejuni Cas9 enables efficient gene activation and base editing

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing

Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficacies

Engineering a Transposon-Associated TnpB-ωRNA System for Efficient Gene Editing and Phenotypic Correction of a Tyrosinaemia Mouse Model

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Enhanced Mammalian Genome Editing by New Cas12a Orthologs with Optimized Crrna Scaffolds

Engineered domain-inlaid Nme2Cas9 adenine base editors with increased on-target DNA editing and targeting scope

Effective genome editing with an enhanced ISDra2 TnpB system and deep learning-predicted ωRNAs

Compact Cje3Cas9 for Efficient in Vivo Genome Editing and Adenine Base Editing.

Engineering Nme2Cas9 Adenine Base Editors with Improved Activity and Targeting Scope

Design and application of the transformer base editor in mammalian cells and mice